Abstract Background Coronavirus disease 2019 (COVID-19) is now a global public threat. Given the pandemic of COVID-19. the economic impact of COVID-19 is essential to add value to the policy-making process. We retrospectively conducted a cost and affordability analysis to determine the medical costs of COVID-19 patients in China. https://www.greenresourcesredux.com/product-category/low-sugar/